Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| (NASDAQ: CMPX) | Delayed: 0.86 -0.04 (4.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.90 | 52 Week High | $ | |||
| Open | $0.90 | 52 Week Low | $ | |||
| Day High | $0.91 | P/E | N/A | |||
| Day Low | $0.86 | EPS | $ | |||
| Volume | 2,038,935 | |||||
